BenevolentAI
investment highlights market leader in drug discovery with and technologically differentiated approach robust with patents on drug pipeline and copyright and trade secrets on our technology platform cant platform scale and internal capability flexible business model with revenue opportunities to extend cash runway rich portfolio of drug programmes all generated from the benevolent platform near and medium term key value in points high value and successful commercial partnership proving strategic validation world renowned board and experienced leadership team | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
72 of 74
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Presentation
October 2022
investment highlights market leader in drug discovery with and technologically differentiated approach robust with patents on drug pipeline and copyright and trade secrets on our technology platform cant platform scale and internal capability flexible business model with revenue opportunities to extend cash runway rich portfolio of drug programmes all generated from the benevolent platform near and medium term key value in points high value and successful commercial partnership proving strategic validation world renowned board and experienced leadership team | BenevolentAI
Related slides by other companies
System1
Investor Presentation
August 2023
investment highlights a | System1
System1
Investor Presentation
November 2022
investment highlights a | System1
Absci
IPO
July 2021
integrated drug creation platform | Absci
Absci
IPO
July 2021
integrated drug creation platform | Absci
Other recent decks by BenevolentAI
See all presentations (11 decks)
Investor Presentation
September 2024
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights